Source: Annual Congress 2004 - PG12 - Asthma: from bench to bedside
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bel (Leiden, The Netherlands). Evaluation and management of difficult-to-control asthma. Annual Congress 2004 - PG12 - Asthma: from bench to bedside

Member's Comments

No comment yet.

Related content which might interest you: Management of severe and difficult-to-treat asthma Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 Acute severe asthma: evidence-based management of asthma exacerbations Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008 Evaluation of the difficult-to-treat severe asthma patient in the clinic Source: Eur Respir Mon 2011; 51: 16-27 Year: 2011 The management of mild asthma Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020 Year: 2021 Assessing severe asthma Source: Eur Respir J 2016; 48: 611-613 Year: 2016 Knowledge of asthma is associated with inhalation technique in elderly patients with asthma Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 The use of omalizumab in the management of severe chronic paediatric asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Efficacy of carbamazepine in treatment of bronchial asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Effectiveness of omalizumab in improving quality of life in patients with ‘steroid-resistant‘ asthma and severe allergic rhinitis Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Perception of asthma management quality by asthmatic patients Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015